Agneepath, Hum and Khuda Gawah are a testament to the Bachchan-Mukul Anand actor-director chemistry. Of the three, Hum is a natural crowd-pleaser, says Sukanya Verma.
The latest updates from the Tamil film industry.
The vaccine candidate, ZyCoV-D, showed a "strong immune response" in animal studies, and the antibodies produced were able to completely neutralise the wild type virus, Zydus said. The 12 institutes have been asked by the ICMR to fast track clinical trials of the vaccine as it is being considered as one of the top priority projects which are being monitored at the topmost level of the government.
What have your favourite celebs posted on social media?
Rules for market infrastructure institutions such as stock exchanges, clearing corporations, and depositories have come under review by Sebi after five years.
A look at the birthday girl's HOTTEST backless avatars on and off screen.
Maintaining that India wants good relations with Pakistan, Union Home Minister Rajnath Singh said resumption of stalled talks with Islamabad was possible if there was an improvement in the situation.
The top posts on social media from your favourite Bollywood celebrities.
Rajinikanth is back to what he does best!
Two successive Rajni flops could well mean that Tamil cinema might come to a grinding halt, affecting the careers of other big-ticket actors, banners and filmmakers, says N Sathiya Moorthy
The controversial Control of Terrorism and Organised Crime Bill was passed by the Gujarat assembly on Tuesday, which allows police to intercept and record telephonic conversations and submit them in court as evidence.
We bring you glimpses of the Raksha Bandhan moments in Bollywood.
'If Haider petitions the court and the government for legitimate rights it is called minority appeasement, but when Hardik orchestrates violence he is lionised, romanticised and given huge media space that ends up both legitimising and oxygenating his movement, no matter how contrary it is to the Rule of Law,' argues Shehzad Poonawalla.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances